Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04299880 |
| Title | Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Boston Biomedical, Inc |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | FRA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Winship Cancer Institute, Emory University | Atlanta | Georgia | 30322 | United States | Details | |
| Maine Center for Cancer Medicine | Scarborough | Maine | 04074 | United States | Details | |
| OHSU Knight Cancer Institute | Portland | Oregon | 97239 | United States | Details | |
| Centre Antoine Lacassagne | Nice | 06100 | France | Details | ||
| Kanagawa Cancer Center | Yokohama | Kanagawa | 241-8515 | Japan | Details | |
| Kyorin University Hospital | Tokyo | 181-8611 | Japan | Details | ||
| Taipei Veterans General Hospital | Taipei City | 11217 | Taiwan | Details |